Professor Dr. Veysel Sabri Hançer graduated from Karşıyaka High School (Izmir, Turkey) in 1995 and Ege University Faculty of Science in 1999. After completing his Master's Degree at Ege University in 2001, he completed his PhD in 2009 at Istanbul University Molecular Biology and Genetics program. He studied at Molecular Hematology laboratory in Istanbul University between 2001 and 2010. Dr.Hancer received his Associate Professor and Professor degrees in 2013 and 2018 respectively. He is currently the head of the Department of Medical Biology, Faculty of Medicine, Istinye University. He is the ...
Professor Dr. Veysel Sabri Hançer graduated from Karşıyaka High School (Izmir, Turkey) in 1995 and Ege University Faculty of Science in 1999. After completing his Master's Degree at Ege University in 2001, he completed his PhD in 2009 at Istanbul University Molecular Biology and Genetics program. He studied at Molecular Hematology laboratory in Istanbul University between 2001 and 2010. Dr.Hancer received his Associate Professor and Professor degrees in 2013 and 2018 respectively. He is currently the head of the Department of Medical Biology, Faculty of Medicine, Istinye University. He is the author of numerous international scientific articles and national / international awards with h-index of 13. His research intrests are cancer genetics and thrombosis genetics. He is a member of the Editorial Board of the Journal of Human Genetics & Embriology and the editor of the Turkish Journal of Hematology. Dr.Hancer is a member of Turkish Hematology Association and Medical Biology and Genetics Association. He speaks English and is married with two children.
Articles
Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients ,2019
Prevalence of human papilloma virus types in Turkish and Albanian women ,2018
A Novel Ganciclovir Resistance Mutation in the UL97 Gene of the HHV-5 in an Adult Hematopoietic Stem Cell Transplant Recipient ,2017
Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment ,2018
Novel Pathological Mutation (c.870 GA, p.Trp290stop) in ARSB of Mucopolysaccharidosis Type VI Patients ,2019
Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation ,2019
Evaluation of Tissue Factor -603 A/G Promoter Gene Polymorphism in Thrombotic Processes in Patients with Antiphospholipid Syndrome ,2019
A novel ATP6V0A2 mutation causing recessive cutis laxa with unusual manifestations of bleeding diathesis and defective wound healing ,2018
Prophylactic Eculizumab Use in Kidney Transplantation A Review of the Literature and Report of a Case with Atypical Hemolytic Uremic Syndrome ,2015
P-selectin glycoprotein ligand-1 variable number of tandem repeats polymorphism in young myocardial infarction patients ,2016
Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up ,2017
β globin mutations in Turkish, Northern Iraqi and Albanian patients with β thalassemia major ,2018
Three Factor 11 mutations associated with Factor XI deficiency in a Turkish family ,2018
Glycoprotein Ibα Kozak polymorphism in patients presenting with early-onset acute coronary syndrome. ,2016
Renal outcome with eculizumab in two diarrhea-associated haemolytic-uremic syndrome cases with severe neurologic involvement. ,2014
Three Novel Calreticulin Mutations in Two Turkish Patients ,2017
Dual effects of testosterone in Behcet s disease implications for a role in disease pathogenesis ,2016
Non invasive prenatal diagnosis of fetal RhD by using free fetal DNA ,2015
The Relationship between P Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome A Pilot Case Control Study ,2014
MPL W515L K mutations in chronic myeloproliferative neoplasms ,2013
Coronary artery ectasia is associated with the c 894G T Glu298Asp polymorphism of the endothelial nitric oxide synthase gene ,2014
Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab ,2013
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation ,2012
The clinical significance of JAK2V617F mutation for Philadelphia negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis ,2012
Glycoprotein Ib alpha Kozak polymorphism in ischemic stroke ,2012
The impact of platelet membrane glycoprotein Ib alpha and Ia IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome ,2012
Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm ,2012
ADAMTS 13 gene expression in antiphospholipid syndrome ,2011
Comparison of KRAS Mutation Tests in Colorectal Cancer Patients ,2011
Polymorphisms of the angiotensin converting enzyme and angiotensinogen gene in patients with atrial fibrillation ,2011
Overexpression of Fc Mu Receptor FCMR TOSO Gene In Chronic Lymphocytic Leukemia Patients ,2012
Cytotoxic T Lymphocyte Antigen 4 CTLA 4 A49G Polymorphism and Autoimmune Blood Diseases ,2010
Impact of genetic polymorphisms on platelet function and aspirin resistance ,2010
The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome ,2010
Angiotensin converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia is DD genotype helpful in predicting syncope risk ,2008
The association of P selectin glycoprotein ligand 1 VNTR polymorphisms with coronary stent restenosis ,2007
The association between factor XIII Val34Leu polymorphism and early myocardial infarction ,2006
Turkish population data on the factor XIII Val34Leu glycoprotein GP Ib Kozak and P selectin glycoprotein ligand 1 PSGL 1 loci ,2005
Factor XIII Val34Leu polymorphism does not contribute to the prevention of trombotic complication in patients with antiphospholipid syndrome ,2004
Reports
Kruppel Like Factor 4 Gene Expression and DNA Methylation in Patinet with Type 2 Diabetes and Diabetic Nephropathy - COŞKUN ZEYNEP MİNE, ERSÖZ MELİKE, ADAŞ MİNE, HANÇER VEYSEL SABRİ, BOYSAN ŞERİFE NUR, GÖNEN MUSTAFA SAİT, ACAR AYNUR
Two novel calreticulin mutations in a turkish patient with primary myelofibrosis: c.1116delA and c.1120A>C. - güvenç serkan,HANÇER VEYSEL SABRİ,uslu neslihan,ARAT MUTLU,küçükkaya reyhan
Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations. - TOKGÖZ HÜSEYİN,ÇALIŞKAN ÜMRAN,küçükkaya reyhan,demir ahmet,HANÇER VEYSEL SABRİ
The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma. - bozkurt mustafa,OKUTUR SADİ KEREM,aydın kübra,NAMAL ESAT,ÖZTÜRK AKIN,plancı kezban nur,HANÇER VEYSEL SABRİ
Is the Glu298Asp polymorphism of Endothelial Nitric Oxide Synthesis Increase the Risk of Stent Thrombosis? - yalçın ahmet arif,ÖZBAY ÖZYILMAZ SİNEM,aktürk ibrahim faruk,HANÇER VEYSEL SABRİ,uzun fatih,ertürk mehmet,birand ali,ender ömer
Investigation of Arrhythmia Markers and KCNJ8-S422L Gene Mutation in a Population with Early Repolarization Pattern on ECG - ERMİŞ EMRAH,DEMİRELLİ SELAMİ,ipek emrah,HANÇER VEYSEL SABRİ,poyraz esra
The clinical significance of JAK2 V617F mutation for Philedelphia-negative chronic myeloproliferative diseases in patients with splanchnic vein thrombosis - yönal ipek,pınarbaşı binnur,hindilerden fehmi,HANÇER VEYSEL SABRİ,NALÇACI MELİHA,küçükkaya reyhan
Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome. - yönal ipek,hindilerden fehmi,HANÇER VEYSEL SABRİ,ARTIM ESEN BAHAR,NALÇACI MELİHA,küçükkaya reyhan
Tissue factor -603A/G polymorphism and tissue factor levels in patients with antiphospholipid syndrome. - kahraman resul,HANÇER VEYSEL SABRİ,küçükkaya reyhan
ADAMTS-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome - HANÇER VEYSEL SABRİ,küçükkaya reyhan,SARIKAYA AYŞEGÜL
P-selectin glycoprotein ligand 1 VNTR polymorphisms in systemic sclerosis - taranoğlu özer,HANÇER VEYSEL SABRİ,küçükkaya reyhan,İNANÇ MURAT
The association between factor XIII Val34Leu polymorphism and early myocardial infarction - ÖZBEN SADIÇ BESTE,BİLGE AHMET KAYA,HANÇER VEYSEL SABRİ,ÖNCÜL AYTAÇ,küçükkaya reyhan,NALÇACI MELİHA
The effect of stem cell transplantation on social and economic status in a developing country on family basis - turgut esengül,kaftancıoğlu ülkü,cesur vesile,akgül narin,ARTIM ESEN BAHAR,HANÇER VEYSEL SABRİ,BEŞIŞIK SEVGİ,SARGIN FATMA DENİZ
HLA Full Match Donors. - kaftancıoğlu ülkü,turgut esengül,HANÇER VEYSEL SABRİ,cesur vesile,akgül narin,ARTIM ESEN BAHAR
Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome - küçükkaya reyhan,HANÇER VEYSEL SABRİ,İNANÇ MURAT,NALÇACI MELİHA,pekçelen yüksel
